The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Overall survival (OS) analysis of IMpower150, a randomized Ph 3 study of atezolizumab (atezo) + chemotherapy (chemo) ± bevacizumab (bev) vs chemo + bev in 1L nonsquamous (NSQ) NSCLC.
 
Mark A. Socinski
Honoraria - AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech
Consulting or Advisory Role - Genentech
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech
Research Funding - Genentech; Pfizer (Inst)
 
Robert M. Jotte
Honoraria - Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Federico Cappuzzo
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; pfizer; Roche/Genentech
 
Francisco Jorquera Orlandi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Bristol-Myers Squibb; Lilly; MSD Oncology; Pfizer; Roche/Genentech
Speakers' Bureau - AstraZeneca/MedImmune
Research Funding - Amgen; Astellas Medivation; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Celltrion; Genentech/Roche; MSD Oncology
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech/Roche; Genentech/Roche; MSD Oncology; Pfizer; Roche
 
Daniil Stroyakovskiy
No Relationships to Disclose
 
Naoyuki Nogami
No Relationships to Disclose
 
Delvys Rodriguez-Abreu
Consulting or Advisory Role - Hoffmann-La Roche, Bristol-Myers Squibb, MSD, Boehringer- Ingelheim
Speakers' Bureau - Hoffmann-La Roche, Bristol-Myers Squibb, MSD, Boehringer- Ingelheim
Travel, Accommodations, Expenses - Hoffmann-La Roche, Bristol-Myers Squibb, MSD, Boehringer- Ingelheim
 
Denis Moro-Sibilot
Honoraria - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
 
Christian A. Thomas
Honoraria - AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech; Janssen Oncology
Consulting or Advisory Role - AstraZeneca; Celgene; Genentech
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Genentech
Travel, Accommodations, Expenses - Celgene; Genentech
 
Fabrice Barlesi
Honoraria - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Pierre Fabre; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Pierre Fabre (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Roche/Genentech
 
Gene Grant Finley
Speakers' Bureau - Astellas Medivation; Boehringer Ingelheim; Bristol-Myers Squibb; Merck
 
Claudia Kelsch
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Anthony Lee
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Shelley Coleman
Employment - Genentech
Stock and Other Ownership Interests - Celgene; Gilead Sciences; Johnson & Johnson; Merck; Roche/Genentech; Teva
Travel, Accommodations, Expenses - Genentech
 
Yijing Shen
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Marcin Kowanetz
Employment - Genentech; Pfizer (I)
Stock and Other Ownership Interests - Roche
 
Ariel Lopez-Chavez
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
 
Alan Sandler
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Martin Reck
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche/Genentech
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; MSD Oncology; Novartis; Pfizer; Roche/Genentech